Every human being should watch this:
Former CEO of Citibank holds a stunning speech at the St James Ethics and the Wheeler Centre debate about meat consumption:
Und hier auf Deutsch:
Wahnsinn, jetzt ist es offiziell so. Die WHO stuft – basierend auf 800 Studien – verarbeitetes Fleisch als krebserregend ein: https://www.tagesschau.de/inland/who-fleisch-krebs-101.html
“Das Risiko steigt demnach umso stärker, je mehr Fleisch ein Mensch isst. “Jede verzehrte Portion verarbeiteten Fleischs von täglich 50 Gramm erhöht das Darmkrebsrisiko um 18 Prozent”, hieß es in der IARC-Studie. Eine Arbeitsgruppe aus 22 Experten hatte mehr als 800 Studien über die Folgen des Fleischkonsums ausgewertet. (…) Es gebe “starke Anzeichen” für einen direkten Zusammenhang zwischen dem Konsum von rotem Fleisch und dem Risiko, an Darm-, Bauchspeicheldrüsen- und Prostatakrebs zu erkranken.”
What would happen if you centered your diet around vegetables, the most nutrient-dense food group?
“The plant-based nature of the diet may trump the caloric restriction, though, since the one population that lives even longer than the Okinawa Japanese don’t just eat a 98% meat-free diet, they eat 100% meat-free. The Adventist vegetarians in California, with perhaps the highest life expectancy of any formally described population.”
More than two-thirds of Americans over age 60 have diverticulosis, but it was nearly unknown a century ago and remained extremely rare among populations eating whole food plant-based diets.
In medicine, there is often the concern that a patient will not respond to a particular treatment, but in a turn for the books, physicians are now worried that a new cancer treatment might be so effective at eliminating tumors that it does more harm than good.After receiving a single treatment of a novel combination therapy, a woman’s tumor seemingly “dissolved” from her chest in just three weeks, leaving her with a gaping hole in its place. The patient received the same cocktail of skin cancer drugs as almost 150 individuals enrolled in a clinical trial designed to test whether one of the therapies worked better on its own or when combined with another. While most patients did significantly better on the combination therapy, researchers were left gobsmacked by this woman’s rapid and dramatic response and have consequently described her case in the New England Journal of Medicine, alongside the trial results.The therapies the scientists were investigating were the FDA-approved melanoma drugs Yervoy (ipilimumab) and Opdivo (nivolumab), which are both antibodies …